Rhythm: therapies for the treatment of rare genetic disorders
Hi guys,
Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity.
Long:
Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity.
Long:
- LMT 1- 19.9$ (20 % of the planned investment amount)
- LMT 2- 19.21$ (40 % of the planned investment amount)
- LMT 3- 18,31$ (40 % of the planned investment amount)
TP:31.4$
Comments and likes are greatly appreciated.
I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions and this is not a call for investment. I am not receiving compensation for it . I have no business relationship with any company whose stock is mentioned in this article.